Predicting concentrations of trace organic compounds in municipal wastewater treatment plant sludge and biosolids using the PhATE™ model

被引:15
作者
Cunningham, Virginia L.
D'Aco, Vincent J.
Pfeiffer, Danielle
Anderson, Paul D.
Buzby, Mary E.
Hannah, Robert E.
Jahnke, James
Parke, Neil J.
机构
[1] Sustainability Sciences LLC, Hatboro, PA, 19040
[2] Quantum Management Group Inc, Clifton, NJ
[3] ARCADIS U.S., San Francisco, CA
[4] ARCADIS U.S., Chelmsford, MA
[5] Merck and Company, Whitehouse Station, NJ
[6] GlaxoSmithKline, Philadelphia, PA
[7] Eli Lilly and Company, Indianapolis, IN
关键词
Biosolids phate [!sup]tm[!/sup; Pharmaceutical model;
D O I
10.1002/ieam.1274
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This article presents the capability expansion of the PhATE (TM) (pharmaceutical assessment and transport evaluation) model to predict concentrations of trace organics in sludges and biosolids from municipal wastewater treatment plants (WWTPs). PhATE was originally developed as an empirical model to estimate potential concentrations of active pharmaceutical ingredients (APIs) in US surface and drinking waters that could result from patient use of medicines. However, many compounds, including pharmaceuticals, are not completely transformed in WWTPs and remain in biosolids that may be applied to land as a soil amendment. This practice leads to concerns about potential exposures of people who may come into contact with amended soils and also about potential effects to plants and animals living in or contacting such soils. The model estimates the mass of API in WWTP influent based on the population served, the API per capita use, and the potential loss of the compound associated with human use (e.g., metabolism). The mass of API on the treated biosolids is then estimated based on partitioning to primary and secondary solids, potential loss due to biodegradation in secondary treatment (e.g., activated sludge), and potential loss during sludge treatment (e.g., aerobic digestion, anaerobic digestion, composting). Simulations using 2 surrogate compounds show that predicted environmental concentrations (PECs) generated by PhATE are in very good agreement with measured concentrations, i.e., well within 1 order of magnitude. Model simulations were then carried out for 18 APIs representing a broad range of chemical and use characteristics. These simulations yielded 4 categories of results: 1) PECs are in good agreement with measured data for 9 compounds with high analytical detection frequencies, 2) PECs are greater than measured data for 3 compounds with high analytical detection frequencies, possibly as a result of as yet unidentified depletion mechanisms, 3) PECs are less than analytical reporting limits for 5 compounds with low analytical detection frequencies, and 4) the PEC is greater than the analytical method reporting limit for 1 compound with a low analytical detection frequency, possibly again as a result of insufficient depletion data. Overall, these results demonstrate that PhATE has the potential to be a very useful tool in the evaluation of APIs in biosolids. Possible applications include: prioritizing APIs for assessment even in the absence of analytical methods; evaluating sludge processing scenarios to explore potential mitigation approaches; using in risk assessments; and developing realistic nationwide concentrations, because PECs can be represented as a cumulative probability distribution. Finally, comparison of PECs to measured concentrations can also be used to identify the need for fate studies of compounds of interest in biosolids. Integr Environ Assess Manag 2012; 8: 530542. (c) SETAC
引用
收藏
页码:530 / 542
页数:13
相关论文
共 63 条
[1]  
Anderson P.O., 2002, Handbook of clinical drug data
[2]   Screening analysis of human pharmaceutical compounds in US surface waters [J].
Anderson, PD ;
D'Aco, VJ ;
Shanahan, P ;
Chapra, SC ;
Buzby, ME ;
Cunningham, VL ;
Duplessie, BM ;
Hayes, EP ;
Mastrocco, FJ ;
Parke, NJ ;
Rader, JC ;
Samuelian, JH ;
Schwab, BW .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2004, 38 (03) :838-849
[3]  
[Anonymous], SRSK5T09 WAT ENV RES
[4]  
BARR WH, 1972, CLIN PHARMACOL THER, V13, P97
[5]   Analysis and occurrence of estrogenic hormones and their glucuronides in surface water and waste water in The Netherlands [J].
Belfroid, AC ;
Van der Horst, A ;
Vethaak, AD ;
Schäfer, AJ ;
Rijs, GBJ ;
Wegener, J ;
Cofino, WP .
SCIENCE OF THE TOTAL ENVIRONMENT, 1999, 225 (1-2) :101-108
[6]  
Bock Michael, 2010, Integrated Environmental Assessment and Management, V6, P393, DOI [10.1897/IEAM_2009-070.1, 10.1002/ieam.134]
[7]  
BURROWS GE, 1980, J AM VET MED ASSOC, V176, P1072
[8]   An Assessment of Potential Exposure and Risk from Estrogens in Drinking Water [J].
Caldwell, Daniel J. ;
Mastrocco, Frank ;
Nowak, Edward ;
Johnston, James ;
Yekel, Harry ;
Pfeiffer, Danielle ;
Hoyt, Marilyn ;
DuPlessie, Beth M. ;
Anderson, Paul D. .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2010, 118 (03) :338-344
[9]   Removal of pharmaceuticals in sewage treatment plants in Italy [J].
Castiglioni, S ;
Bagnati, R ;
Fanelli, R ;
Pomati, F ;
Calamari, D ;
Zuccato, E .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2006, 40 (01) :357-363
[10]   Detection of the antimicrobials triclocarban and triclosan in agricultural soils following land application of municipal biosolids [J].
Cha, Jongmun ;
Cupples, Alison M. .
WATER RESEARCH, 2009, 43 (09) :2522-2530